180 related articles for article (PubMed ID: 37478249)
1. Exploring the inhibition mechanism of interleukin-1-beta in gouty arthritis by polygonum cuspidatum using network pharmacology and molecular docking: A review.
Ge X; Zhang Y; Fang R; Zhao J; Huang J
Medicine (Baltimore); 2023 Jul; 102(29):e34396. PubMed ID: 37478249
[TBL] [Abstract][Full Text] [Related]
2. Clinical efficacy evaluation and potential mechanism prediction on Guizhi-Shaoyao-Zhimu decoction in the treatment of gouty arthritis based on meta-analysis, network pharmacology analysis, and molecular docking.
Qu P; Wang H; Wang W; Hu Q; Du S; Peng Z; Tang X
Medicine (Baltimore); 2023 Nov; 102(47):e35973. PubMed ID: 38013344
[TBL] [Abstract][Full Text] [Related]
3. Preliminary study on molecular mechanism of COVID-19 intervention by Polygonum cuspidatum through computer bioinformatics.
Liu T; Han R; Yan Y
Medicine (Baltimore); 2024 Jan; 103(2):e36918. PubMed ID: 38215091
[TBL] [Abstract][Full Text] [Related]
4. Treatment of gouty arthritis with traditional Chinese medicine decoction: Meta-analysis, network pharmacology analysis, and molecular docking.
Qu P; Du S; Wang W; Peng Z; Hu Q; Wang H; Tang X
Medicine (Baltimore); 2024 Jan; 103(1):e36722. PubMed ID: 38181263
[TBL] [Abstract][Full Text] [Related]
5. Exploring the mechanism of Xiaoqinglong decoction in the treatment of infantile asthma based on network pharmacology and molecular docking.
Chen D; Chen Q; Zhao K; Guo Y; Huang Y; Yuan Z; Cai Y; Li S; Xu J; Lin X
Medicine (Baltimore); 2023 Jan; 102(2):e32623. PubMed ID: 36637916
[TBL] [Abstract][Full Text] [Related]
6. [Mechanism and experimental verification of "Polygoni Cuspidati Rhizoma et Radix-Ligustri Lucidi Fructus" combination in treatment of acute gouty arthritis based on network pharmacology].
DU K; Wang WD; Han B; Wang YF; Wang ZP
Zhongguo Zhong Yao Za Zhi; 2022 Mar; 47(6):1677-1686. PubMed ID: 35347967
[TBL] [Abstract][Full Text] [Related]
7. Research on the effect and underlying molecular mechanism of Cangzhu in the treatment of gouty arthritis.
Li C; Wang C; Guo Y; Wen R; Yan L; Zhang F; Gong Q; Yu H
Eur J Pharmacol; 2022 Jul; 927():175044. PubMed ID: 35643303
[TBL] [Abstract][Full Text] [Related]
8. Investigation of the Active Ingredients and Mechanism of
Bi J; Lin Y; Sun Y; Zhang M; Chen Q; Miu X; Tang L; Liu J; Zhu L; Ni Z; Wang X
Drug Des Devel Ther; 2021; 15():1075-1089. PubMed ID: 33727796
[TBL] [Abstract][Full Text] [Related]
9. Exploration of the mechanism of Zisheng Shenqi decoction against gout arthritis using network pharmacology.
Li WH; Han JR; Ren PP; Xie Y; Jiang DY
Comput Biol Chem; 2021 Feb; 90():107358. PubMed ID: 33243703
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic effects of Siegesbeckia orientalis L. and its active compound luteolin in rheumatoid arthritis: network pharmacology, molecular docking and experimental validation.
Xiao B; Li J; Qiao Z; Yang S; Kwan HY; Jiang T; Zhang M; Xia Q; Liu Z; Su T
J Ethnopharmacol; 2023 Dec; 317():116852. PubMed ID: 37390879
[TBL] [Abstract][Full Text] [Related]
11. Component identification of modified sanmiao pills by UPLC-Xevo G2-XS QTOF and its anti-gouty arthritis mechanism based on network pharmacology and experimental verification.
Chen R; Li F; Zhou K; Xing M; Zhang X; Zhao X; Wu C; Han Z; Zhou Y; Yan L; Xia D
J Ethnopharmacol; 2023 Jul; 311():116394. PubMed ID: 36940736
[TBL] [Abstract][Full Text] [Related]
12. Identification of Interleukin-1-Beta Inhibitors in Gouty Arthritis Using an Integrated Approach Based on Network Pharmacology, Molecular Docking, and Cell Experiments.
Zeng L; Lin Z; Kang P; Zhang M; Tang H; Li M; Xu K; Liu Y; Jiang Z; Huo S
Evid Based Complement Alternat Med; 2022; 2022():2322417. PubMed ID: 36193152
[TBL] [Abstract][Full Text] [Related]
13. Potential Molecular Mechanisms of Ephedra Herb in the Treatment of Nephrotic Syndrome Based on Network Pharmacology and Molecular Docking.
Yao T; Wang Q; Han S; Lu Y; Xu Y; Wang Y
Biomed Res Int; 2022; 2022():9214589. PubMed ID: 35837376
[TBL] [Abstract][Full Text] [Related]
14. Mechanism of ShuiJingDan in Treating Acute Gouty Arthritis Flares Based on Network Pharmacology and Molecular Docking.
Liu Q; Li L; Zheng D; Jin S; Guan X; Fu Z; Xiong Z; Ding H
Drug Des Devel Ther; 2023; 17():3493-3505. PubMed ID: 38034481
[TBL] [Abstract][Full Text] [Related]
15. Potential active compounds and molecular mechanism of Xuefu Zhuyu decoction for atherosclerosis, based on network pharmacology and molecular docking.
Li Y; Liu B; Liu L; Xu Q; Shen Q; Li W; Zhao J
Medicine (Baltimore); 2022 Aug; 101(32):e29654. PubMed ID: 35960089
[TBL] [Abstract][Full Text] [Related]
16. [Mechanism of total flavonoids from Ampelopsis grossedentata against gouty arthritis based on multi-level interactive network and in vivo experimental validation].
Li JC; Li SY; Song Q; Ma EX; Aimaijiang MK
Zhongguo Zhong Yao Za Zhi; 2022 Sep; 47(17):4733-4743. PubMed ID: 36164881
[TBL] [Abstract][Full Text] [Related]
17. The mechanism of Epimedium in the treatment of coronary atherosclerotic heart disease based on network pharmacology, molecular docking, and in vitro studies.
Xin G; Yuedong Y; Xuemei S; Chenhan M; Meng Z; Chenbo Z; Ning G; Xindong W
Eur Rev Med Pharmacol Sci; 2022 Apr; 26(7):2478-2488. PubMed ID: 35442463
[TBL] [Abstract][Full Text] [Related]
18. Unraveling the pharmacodynamic substances and possible mechanism of Trichosanthis Pericarpium in the treatment of coronary heart disease based on plasma pharmacochemistry, network pharmacology and experimental validation.
Zhang XY; Xia KR; Wang YN; Liu P; Shang EX; Liu CY; Liu YP; Qu D; Li WW; Duan JA; Chen Y; Zhang HQ
J Ethnopharmacol; 2024 May; 325():117869. PubMed ID: 38342153
[TBL] [Abstract][Full Text] [Related]
19. Study on the effect and mechanism of quercetin in treating gout arthritis.
Feng W; Zhong XQ; Zheng XX; Liu QP; Liu MY; Liu XB; Lin CS; Xu Q
Int Immunopharmacol; 2022 Oct; 111():109112. PubMed ID: 35932610
[TBL] [Abstract][Full Text] [Related]
20. Exploring the mechanism and experimental validation of Fuzi Lizhong Tang in treating gastric cancer based on network pharmacology and molecular docking.
Zhang FY; Guo SC
Eur Rev Med Pharmacol Sci; 2023 Oct; 27(19):9192-9204. PubMed ID: 37843333
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
